Exagen Inc (XGN) — Cash Flow-to-Debt Ratio
Exagen Inc (XGN) has a Cash Flow-to-Debt Ratio of -0.28x as of March 2026, meaning its operating cash flow of $-10.42 Million could theoretically repay 0% of its total liabilities ($37.52 Million) in one year. Check Exagen Inc (XGN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Exagen Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Exagen Inc across 13 annual periods. Also explore XGN total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Exagen Inc (2012–2025)
Year-by-year debt coverage analysis for Exagen Inc. For market capitalisation and broader financial context, see Exagen Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.34x | $-13.62 Million | $40.57 Million | ▲ +11.1% |
| 2024 | -0.38x | $-13.28 Million | $35.15 Million | ▲ +10.5% |
| 2023 | -0.42x | $-14.46 Million | $34.25 Million | ▲ +42.5% |
| 2022 | -0.73x | $-32.14 Million | $43.76 Million | ▼ -39.6% |
| 2021 | -0.53x | $-20.27 Million | $38.51 Million | ▼ -36.5% |
| 2020 | -0.39x | $-14.08 Million | $36.54 Million | ▼ -29.6% |
| 2019 | -0.30x | $-9.71 Million | $32.65 Million | ▼ -13.9% |
| 2018 | -0.26x | $-9.30 Million | $35.62 Million | ▲ +40.4% |
| 2017 | -0.44x | $-10.97 Million | $25.03 Million | ▼ -35.5% |
| 2015 | -0.32x | $-11.90 Million | $36.81 Million | ▲ +6.3% |
| 2014 | -0.35x | $-10.77 Million | $31.20 Million | ▲ +19.5% |
| 2013 | -0.43x | $-6.87 Million | $16.00 Million | ▲ +63.0% |
| 2012 | -1.16x | $-7.48 Million | $6.44 Million | — |